Overview

Pedaling at a Low-Moderate Intensity During Chemotherapy Administration

Status:
Enrolling by invitation
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the feasibility of completing a low-moderate intensity pedaling session concurrent to chemotherapy treatment for colorectal cancer. Secondary objectives for this study consist of evaluating the role of pedaling on sarcopenia rates, quality of life markers, chemotherapy side effects, rate of hospital admissions, and treatment delays.
Phase:
N/A
Details
Lead Sponsor:
Rush University Medical Center